Recovery Compound

Pentadeca Arginate (PDA)

Arginate-salt analog of BPC-157 developed for improved injection stability and tissue repair.

Scientific Overview

Pentadeca Arginate (PDA) is a 15-amino-acid peptide derived from the BPC-157 sequence and complexed with an arginate salt for greater stability and longer shelf life than BPC-157 acetate. Marketed as a research-grade alternative as compounding pharmacies pivoted away from BPC-157 after the FDA's 2023 503A removal. Human trial evidence is limited.

Key Research Benefits

  • Tendon and ligament healing
  • Better stability than BPC-157 acetate
  • Anti-inflammatory

Potential Side Effects

Injection-site irritation
Limited human trial data

Research Protocols

Common Dosages

Repair

250-500 mcg
1-2x daily SC

4-8 week cycles

Note: Dosages listed are common research protocols found in peer-reviewed literature and clinical trials. Individual results and requirements may vary significantly in a research context.

Dose Calculator

🧮 Peptide Reconstitution Calculator

mg

Total amount of peptide in the vial.

mL

Volume of water used to mix.

mcg

Draw to this mark

10 Units

or 0.10 mL on a U-100 syringe

Concentration:2.50 mg/mL
Peptide per Unit:25.00 mcg/unit
*Always double-check your calculations. This tool is for educational purposes only.

Explore Pentadeca Arginate (PDA)

Where to source

Vendors with public COAs that stock this category. Affiliate links are disclosed.

  • Limitless Life Nootropics
    FL-based research-peptide supplier with Janoshik third-party COAs and a public affiliate program at ~20%.
    COA: JanoshikAffiliate disclosed
  • SwissChems
    60+ peptide catalog with Janoshik COAs; weekly affiliate payouts.
    COA: JanoshikAffiliate disclosed
  • Amino Club
    EU/US-facing vendor with a 20% first-order / 10% recurring affiliate model.
    COA: Third-partyAffiliate disclosed

Stack Pentadeca Arginate (PDA) with…

Curated stacking partners researched alongside Pentadeca Arginate (PDA). Each link opens a dedicated stack page with combined benefits, side-effect overlap, and half-life considerations.

Pentadeca Arginate (PDA) by goal

Read Pentadeca Arginate (PDA)'s profile filtered through specific research goals.

Molecular Profile

linear
BPC-157 arginate salt
15 AA Sequence

Quick Reference

Status
Research Compound
Category
Recovery
Common Dosage
250-500 mcg
1-2x daily SC

Strictly for research purposes. Not for human consumption.

Medical Disclaimer

Information provided on DoseVault is for educational and research purposes only. This website does not advocate for the human use of peptides. Peptides are currently sold as research chemicals and are not FDA-approved for human consumption. Always consult a licensed medical professional before considering any protocol.